APAC
NSAIDs and opioids dominate global pain therapeutics market
NSAIDs and opioids dominate global pain therapeutics market
Regulatory incentives and innovative trial designs also boost market interest.
How can governments stop healthcare inflation from spiraling?
Asia-Pacific medical costs are set to outpace global averages this year.
Rising diabetes cases propel medical devices market toward 8.1% CAGR through 2034
The industry is projected to reach $67.39b by end-period.
AI in precision medicine market to soar to $38.9B by 2034 on 35.5% CAGR
Market growth is driven by ML, deep learning, EHR.
Rising geriatric population drives $510b advance directives market forecast
The elderly population accounts for the largest share of the market.
Global conjunctivitis market to hit $7.2b by 2033
It is driven by rising cases of bacterial, viral, and allergic conjunctivitis
Pharmaceutical industry faces rising revenue delays amidst P&R pressures
US policies are driving global price pressures.
Generative AI and precision medicine fuel rapid growth in biotechnology sector
Hybrid modelling and simulations reduce lab testing and speed up discovery.
Advanced imaging, telemedicine drive heart attack diagnostics market to $21b by 2033
The Asia-Pacific region is expected to see the fastest growth.
Neurocosmetics reshape skincare as 79% favour natural tags
A GlobalData survey showed rising interest in stress-linked skin solutions.
Radiopharma market to hit $21.8b by 2033 on cancer therapy boom
The Asia-Pacific region is projected to have the highest growth rate.
Growing demand for preventive care and therapeutic equipment boosts dental market
Therapeutic dental equipment is the largest segment.
Advances in digital imaging, nanotech drive microscopy market to $11.4b by 2031
APAC is expected to see the fastest growth.
Health sterotypes block early preventative actions amongst Asians: AIA
Rigid beliefs discourage early health action across Asia.
How can drugmakers stand out in a crowded immunology market?
Launching the next autoimmune therapy blockbuster is becoming harder.
Rising metabolic dysfunction drives insulin resistance treatment growth
26.5% of global population had insulin resistance in 2025.
Prefilled auto-injectors market set to hit $11.2b by 2033 amidst homecare shift
Asia-Pacific is emerging as the fastest-growing region.
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential
Why health system research deserves more attention